{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:17:58Z","timestamp":1706573878873},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00105-023-05234-2","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T11:03:27Z","timestamp":1697022207000},"page":"170-175","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Station\u00e4re Psoriasistherapie: Quo vadis?\u00a0\u2013 Eine retrospektive Studie an den Universit\u00e4tskliniken Aachen, Bonn und Essen im Zeitraum von 2010 bis 2019","Inpatient care for psoriasis: quo vadis?\u2014A\u00a0retrospective study at the University Hospitals of Aachen, Bonn, and Essen from 2010 to 2019"],"prefix":"10.1007","volume":"75","author":[{"given":"Sietske","family":"Poortinga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Sondermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meike","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir S.","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Balakirski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Wilsmann-Theis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"issue":"3","key":"5234_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ajd.12097","volume":"55","author":"J Bale","year":"2014","unstructured":"Bale\u00a0J, Chee\u00a0P (2014) Inpatient dermatology: Pattern of admissions and patients\u2019 characteristics in an Australian hospital. Australas J Dermatol 55(3):191\u2013195","journal-title":"Australas J Dermatol"},{"issue":"3","key":"5234_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0733-8635(05)70188-1","volume":"18","author":"R Sowjanya Ayyalaraju","year":"2000","unstructured":"Sowjanya Ayyalaraju\u00a0R, Finlay\u00a0AY (2000) Inpatient dermatology: United Kingdom and United States similarities: moving with the times or being relegated to the back bench? Dermatol Clin 18(3):397\u2013404","journal-title":"Dermatol Clin"},{"issue":"4","key":"5234_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1046\/j.1468-3083.2002.00473.x","volume":"16","author":"I Garc\u00eda-Doval","year":"2002","unstructured":"Garc\u00eda-Doval\u00a0I, Feal\u00a0C, Ros\u00f3n\u00a0E et al (2002) Inpatient dermatology: characteristics of patients and admissions in a\u00a0Spanish hospital. J\u00a0Eur Acad Dermatol Venereol 16(4):334\u2013338","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 5","key":"5234_CR4","first-page":"25","volume":"19","author":"M Augustin","year":"2021","unstructured":"Augustin\u00a0M, Girbig\u00a0G, Kis\u00a0A, Bechara\u00a0FG et al (2021) Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs. J\u00a0Dtsch Dermatol Ges 19(Suppl 5):25\u201353","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"5234_CR5","first-page":"934","volume":"19","author":"A Nast","year":"2021","unstructured":"Nast\u00a0A, Altenburg\u00a0A, Augustin\u00a0M et al (2021) Deutsche S3-Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm \u2013 Teil\u00a01: Therapieziele und Therapie-empfehlungen. J\u00a0Dtsch Dermatol Ges 19(6):934\u2013951","journal-title":"J Dtsch Dermatol Ges"},{"key":"5234_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-005-0103-4","author":"W B\u00f6cking","year":"2005","unstructured":"B\u00f6cking\u00a0W, Ahrens\u00a0U, Kirch\u00a0W, Milakovic\u00a0M (2005) First results of the introduction of DRGs in Germany and overview of experience from other DRG countries. Am J Public Health. https:\/\/doi.org\/10.1007\/s10389-005-0103-4","journal-title":"Am. J. Public Health"},{"issue":"3","key":"5234_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita\u00a0J, Grewal\u00a0S, Langan\u00a0SM et\u00a0al (2017) Psoriasis and comorbid diseases: epidemiology. J\u00a0Am Acad Dermatol 76(3):377\u2013390","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"5234_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/1346-8138.15721","volume":"48","author":"W Sondermann","year":"2021","unstructured":"Sondermann\u00a0W, Fiege\u00a0O, K\u00f6rber\u00a0A, Scherbaum\u00a0N (2021) Psychological burdern of psoriatic patients in a\u00a0German university hospital dermatology department. J\u00a0Dermatol 48(6):794\u2013806","journal-title":"J Dermatol"},{"issue":"1","key":"5234_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaad.2020.08.032","volume":"84","author":"RG Langley","year":"2021","unstructured":"Langley\u00a0RG, Poulin\u00a0Y, Srivastava\u00a0B et al (2021) Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A\u00a0nested case-control analysis. J\u00a0Am Acad Dermatol 84(1):60\u201369","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"5234_CR10","first-page":"1003","volume":"19","author":"AC Pilz","year":"2021","unstructured":"Pilz\u00a0AC, Zink\u00a0A, Schielein\u00a0MC et\u00a0al (2021) Despite large choice of effective therapies: Individuals with psoriasis still seem undertreated. J\u00a0Dtsch Dermatol Ges 19(7):1003\u20131011","journal-title":"J Dtsch Dermatol Ges"},{"issue":"7","key":"5234_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/jdv.17220","volume":"35","author":"A Langenbruch","year":"2021","unstructured":"Langenbruch\u00a0A, Mohr\u00a0N, Kirsten\u00a0N et\u00a0al (2021) Quality of psoriasis care in Germany\u2014results from the nationwide health care studies PsoHealth 2004\u20132017. J\u00a0Eur Acad Dermatol Venereol 35(7):1536\u20131542","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"5234_CR12","first-page":"812","volume":"13","author":"M Krensel","year":"2015","unstructured":"Krensel\u00a0M, Augustin\u00a0M, Rosenbach\u00a0T, Reusch\u00a0M (2015) Waiting time and practice organization in dermatology. J\u00a0Dtsch Dermatol Ges 13(8):812\u2013814","journal-title":"J Dtsch Dermatol Ges"},{"issue":"11","key":"5234_CR13","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/jdv.15044","volume":"32","author":"L Polivka","year":"2018","unstructured":"Polivka\u00a0L, Oubaya\u00a0N, Bachelez\u00a0H et\u00a0al (2018) Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a\u00a0time series in France between 2005 and 2015. J\u00a0Eur Acad Dermatol Venereol 32(11):1920\u20131929","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"5234_CR14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jaad.2019.10.051","volume":"82","author":"BT Cheng","year":"2020","unstructured":"Cheng\u00a0BT, Silverberg\u00a0JI (2020) Predictors of hospital readmission in United States adults with psoriasis. J\u00a0Am Acad Dermatol 82(4):902\u2013909","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5234_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1684\/ejd.2021.4016","volume":"31","author":"N Ninosu","year":"2021","unstructured":"Ninosu\u00a0N, Roehrich\u00a0F, Diehl\u00a0G et al (2021) Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a\u00a0German university hospital. Eur J Dermatol 31(2):183\u2013191","journal-title":"Eur J Dermatol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05234-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05234-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05234-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T19:03:06Z","timestamp":1706554986000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05234-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["5234"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05234-2","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"11 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.\u00a0Sondermann erhielt Honorare und\/oder Reisekostenunterst\u00fctzung f\u00fcr Vortr\u00e4ge, Beratungen und\/oder Studien von AbbVie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, GSK, Janssen, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi Genzyme und UCB ohne Einfluss auf die vorliegende Arbeit. D. Wilsmann-Theis erhielt Honorare und\/oder Reisekostenunterst\u00fctzung f\u00fcr Vortr\u00e4ge, Beratungen und\/oder Studien von Abbott\/AbbVie, Almirall, Amgen, Biogen IDEC GmbH, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Janssen-Cilag, Leo Pharma, Eli Lilly and Company, Hexal, Klinge-Pharma, Merck Serono GmbH, MSD SHARP & DOHME GmbH, Novartis Pharma, Pfizer und UCB ohne Einfluss auf die vorliegende Arbeit. G. Balakirski erhielt Honorare und\/oder Reisekostenunterst\u00fctzung f\u00fcr Vortr\u00e4ge, Beratungen und\/oder Studien von AbbVie, Almirall, Amgen, Boehringer Ingelheim, Celgene, Galderma, Janssen-Cilag, Leo Pharma, Eli Lilly, Novartis, Pfizer, Sanofi Genzyme und UCB Pharma ohne Einfluss auf die vorliegende Arbeit. S. Poortinga erhielt Honorare und\/oder Reisekostenunterst\u00fctzung f\u00fcr Vortr\u00e4ge, Beratungen und\/oder Studien von AbbVie, Amgen, Boehringer Ingelheim, Celgene, Galderma, Janssen-Cilag, Leo Pharma, Eli Lilly, Novartis, Pfizer und UCB Pharma ohne Einfluss auf die vorliegende Arbeit. M.\u00a0F\u00f6rster, A.S.\u00a0Yazdi und T.\u00a0Bieber geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}